Efficacy of mitomycin C in endoscopic dacryocystorhinostomy: a systematic review and meta-analysis
- PMID: 23675423
- PMCID: PMC3652813
- DOI: 10.1371/journal.pone.0062737
Efficacy of mitomycin C in endoscopic dacryocystorhinostomy: a systematic review and meta-analysis
Abstract
Background: A number of published comparative studies have been conducted to evaluate the efficacy and safety of intraoperative mitomycin C (MMC) in endoscopic dacryocystorhinostomy (EN-DCR). However, results have not always been consistent. Therefore, we carried out a meta-analysis to compare the clinical results of EN-DCR with and without MMC.
Methods and findings: A comprehensive literature search of Cochrane Library, PubMed and EMBASE to identify relevant trials comparing EN-DCR with and without MMC. Eleven studies including 574 eyes were included in this meta-analysis. The success was defined as patency of the nasolacrimal canal and symptomatic improvement. There was significantly higher success rate in the MMC group in comparison with control group [RR = 1.12, 95% CI (1.04, 1.20), P = 0.004]. A sensitivity analysis after the non-randomized controlled trials were excluded from the meta-analysis demonstrated no differences compared with the overall results. Subgroup analyses showed that MMC group had a significantly higher success rate than control group in primary and revision EN-DCR, and EN-DCR without silicone intubation, but no difference in the subgroup of with silicone intubation. The size of the osteotomy site was bigger in the MMC group compared to the control group at 3 months [WMD = 7.65, 95% CI (0.33, 14.98), P = 0.041] and 6 months [WMD = 9.28, 95% CI (2.45, 16.11), P = 0.008] after surgery. However, there was statistically significant difference in the osteotomy surface area between the two groups at 12 months after surgery [WMD = 11.63, 95% CI (-1.04, 24.29), P = 0.072].
Conclusion: Intraoperative MMC application seems to be a safe adjuvant that could reduce the closure rate of the osteotomy and enhance the success rate after both primary and revision EN-DCR.
Trial registration: ClinicalTrials.gov NCT01772277.
Conflict of interest statement
Figures







Similar articles
-
Endonasal versus external dacryocystorhinostomy for nasolacrimal duct obstruction.Cochrane Database Syst Rev. 2017 Feb 24;2(2):CD007097. doi: 10.1002/14651858.CD007097.pub3. Cochrane Database Syst Rev. 2017. PMID: 28231605 Free PMC article.
-
Probing for congenital nasolacrimal duct obstruction.Cochrane Database Syst Rev. 2017 Jul 12;7(7):CD011109. doi: 10.1002/14651858.CD011109.pub2. Cochrane Database Syst Rev. 2017. PMID: 28700811 Free PMC article.
-
Mitomycin C versus 5-Fluorouracil for wound healing in glaucoma surgery.Cochrane Database Syst Rev. 2015 Nov 6;2015(11):CD006259. doi: 10.1002/14651858.CD006259.pub2. Cochrane Database Syst Rev. 2015. PMID: 26545176 Free PMC article.
-
Fornix-based versus limbal-based conjunctival trabeculectomy flaps for glaucoma.Cochrane Database Syst Rev. 2015 Nov 25;11(11):CD009380. doi: 10.1002/14651858.CD009380.pub2. Cochrane Database Syst Rev. 2015. Update in: Cochrane Database Syst Rev. 2021 Aug 26;8:CD009380. doi: 10.1002/14651858.CD009380.pub3. PMID: 26599668 Free PMC article. Updated.
-
Intravesical bacillus Calmette-Guerin versus mitomycin C for Ta and T1 bladder cancer.Cochrane Database Syst Rev. 2003;(3):CD003231. doi: 10.1002/14651858.CD003231. Cochrane Database Syst Rev. 2003. Update in: Cochrane Database Syst Rev. 2015 Nov 07;(11):CD003231. doi: 10.1002/14651858.CD003231.pub2. PMID: 12917955 Updated.
Cited by
-
Endoscopic dacryocystorhinostomy as treatment for lower lacrimal pathway obstructions in adults: Review article.Allergy Rhinol (Providence). 2015 Jan;6(1):12-9. doi: 10.2500/ar.2015.6.0116. Allergy Rhinol (Providence). 2015. PMID: 25860166 Free PMC article.
-
Comparison of the effects of Mitomycin-C and sodium hyaluronate/carboxymethylcellulose [NH/CMC] (Seprafilm) on abdominal adhesions.Springerplus. 2016 Jun 23;5(1):846. doi: 10.1186/s40064-016-2359-2. eCollection 2016. Springerplus. 2016. PMID: 27386295 Free PMC article.
-
Topical mitomycin in endoscopic-assisted probing for the treatment of congenital nasolacrimal duct obstruction in older children.Arq Bras Oftalmol. 2020 Jun;83(3):229-235. doi: 10.5935/0004-2749.20200062. Epub 2020 May 29. Arq Bras Oftalmol. 2020. PMID: 32490970 Free PMC article.
-
Intra-Operative Mitomycin-C as Adjuvant Therapy in External and Endonasal Dacryocystorhinostomy: Systematic Review and Meta-Analysis.Ophthalmol Ther. 2020 Jun;9(2):305-319. doi: 10.1007/s40123-020-00253-x. Epub 2020 Apr 27. Ophthalmol Ther. 2020. PMID: 32342404 Free PMC article.
-
Mitomycin-C in dacryocystorhinostomy: From experimentation to implementation and the road ahead: A review.Indian J Ophthalmol. 2015 Apr;63(4):335-9. doi: 10.4103/0301-4738.158082. Indian J Ophthalmol. 2015. PMID: 26044474 Free PMC article. Review.
References
-
- Caldwell GW (1893) Two new operations for obstruction of the nasal duct with preservation of the canaliculi. Am J Ophthalmol 10: 189–191.
-
- McDonogh M, Meiring JH (1989) Endoscopic transnasal dacryocystorhinostomy. J Laryngol Otol 103: 585–587. - PubMed
-
- Korkut AY, Teker AM, Yazici MZ, Kahya V, Gedikli O, et al. (2010) Surgical outcomes of primary and revision endoscopic dacryocystorhinostomy. J Craniofac Surg 21: 1706–1708. - PubMed
-
- Leong SC, Macewen CJ, White PS (2010) A systematic review of outcomes after dacryocystorhinostomy in adults. Am J Rhinol Allergy 24: 81–90. - PubMed
-
- Wakaki S, Marumo H, Tomioka K (1958) Isolation of new fractions of antitumor mitomycins. Antibiot Chemother 8: 228–240. - PubMed
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials